AI May Be Used to Find New Cures in Old Drugs

Newsroom

AI May Be Used to Find New Cures in Old Drugs

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

AI May Be Used to Find New Cures in Old Drugs

Model Medicines Announces Appointment of Tushar Menon, Ph.D. to its Advisory Board

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines Announces Appointment of Tushar Menon, Ph.D. to its Advisory Board

Accelerator-Backed Startups Find COVID-19 Opportunities

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Accelerator-Backed Startups Find COVID-19 Opportunities

Model Medicines Announces Appointment of Steven Muskal, Ph.D. to its Advisory Board

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines Announces Appointment of Steven Muskal, Ph.D. to its Advisory Board

Model Medicines to Participate The Virtual MedInvest Life Science Conference

Lani Nguyen 9/8/21 Lani Nguyen 9/8/21

Model Medicines to Participate The Virtual MedInvest Life Science Conference

September 8-10 2021 • Virtual

Model Medicines Recognized as a “Startup Who is Rising to the Occasion” to fight COVID-19 by GAN

Lani Nguyen 4/22/20 Lani Nguyen 4/22/20

Model Medicines Recognized as a “Startup Who is Rising to the Occasion” to fight COVID-19 by GAN

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines COVID-19 Drug Development Program Highlighted by Nex Cubed Healthcare

Lani Nguyen 4/9/20 Lani Nguyen 4/9/20

Model Medicines COVID-19 Drug Development Program Highlighted by Nex Cubed Healthcare

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines Accepted To Join The Alliance for Artificial Intelligence in Healthcare (AAIH)

Lani Nguyen 4/6/20 Lani Nguyen 4/6/20

Model Medicines Accepted To Join The Alliance for Artificial Intelligence in Healthcare (AAIH)

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines COVID-19 Drug Development Program Highlighted by Catalyst Health 2.0

Lani Nguyen 3/30/20 Lani Nguyen 3/30/20

Model Medicines COVID-19 Drug Development Program Highlighted by Catalyst Health 2.0

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines Highlighted as VC Backed StartUp Battling COVID-19 by MedCityNews

Lani Nguyen 3/29/20 Lani Nguyen 3/29/20

Model Medicines Highlighted as VC Backed StartUp Battling COVID-19 by MedCityNews

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Lani Nguyen 3/28/20 Lani Nguyen 3/28/20

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines Joins The Fight To Battle The Global COVID-19 Pandemic

Lani Nguyen 3/25/20 Lani Nguyen 3/25/20

Model Medicines Joins The Fight To Battle The Global COVID-19 Pandemic

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Lani Nguyen 1/16/20 Lani Nguyen 1/16/20

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines’ CHEMprint™ AI/ML drug discovery platform successfully identified multiple drug candidates that were found to be active against SARS-CoV-2 replication in a live virus study in a human cell line at a hit rate of over 14%.

“AI and ML models... can significantly improve the efficacy of drug discovery.”

Arnab Chatterjee, Ph.D
Calibr at Scripps Research

“We are very pleased with the demonstrated potent antiviral activity of MDL-001.”

Davey Smith, MDUC
San Diego Health

“We are very excited to partner with Model Medicines on this important endeavor to identify novel therapeutics to treat the immediate threat of SARS-CoV-2 today and prepare for the pandemics of tomorrow.”

Sumit Chanda, Ph.D.
Sanford Burnham Prebys

“...a game-changer in the global fight against COVID-19.”

Adolfo Garcia-Sastre, Ph.D
Icahn School of Medicine at Mount Sinai